Suppr超能文献

基于脑代谢物、γ-氨基丁酸和脑血流的磁共振成像对健忘性轻度认知障碍患者进行 Kami Guibi-tang 治疗评估。

Treatment evaluation of Kami Guibi-tang on participants with amnestic mild cognitive impairment using magnetic resonance imaging on brain metabolites, gamma-aminobutyric acid, and cerebral blood flow.

机构信息

Stroke and Neurological Disorders Center, Kyung Hee University Hospital at Gangdong, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.

Department of Biomedical Engineering, Undergraduate School, College of Electronics and Information, Kyung Hee University, Yongin-si, Gyeonggi-do, Republic of Korea.

出版信息

J Appl Clin Med Phys. 2021 Nov;22(11):151-164. doi: 10.1002/acm2.13443. Epub 2021 Oct 11.

Abstract

PURPOSE

To evaluate the effectiveness of Kami Guibi-tang (KGT) in the treatment of mild cognitive impairment (MCI) using magnetic resonance imaging (MRI) on brain metabolites, neurotransmitter, and cerebral blood flow (CBF).

METHODS

We randomly allocated a total of 30 MCI patients to a KGT (N = 16) or a placebo (N = 14) group and performed MRI scans before and after 24 weeks of treatment. The participants underwent brain magnetic resonance spectroscopy and MRI scans to obtain brain metabolites using Point-RESolved Spectroscopy (PRESS) single-voxel spectroscopy, gamma-aminobutyric acid (GABA) neurotransmitter using Mescher-Garwood PRESS, and CBF using pseudocontinuous arterial spin labeling sequences using a 3.0 Tesla MRI system. We analyzed metabolite and neurotransmitter levels and CBF using repeated-measure analysis of variance to evaluate between-subject group effect, within-subject treatment condition effect, and interaction of group by condition (group x condition).

RESULTS

The GABA+/creatine (Cr) ratio values were not significantly different between the before and after treatment conditions. The glutamate complex/Cr ratio difference before and after treatment was lower in the KGT group than in the placebo group, but was not statistically significant (p = 0.077). The result of region of interest-based CBF measurement showed that CBF values were significantly lower after treatment at Cluster 2 for the KGT group (p = 0.003) and the placebo group (p = 0.011), at hippocampus for the KGT group (p = 0.004) and the placebo group (p = 0.008), and at the fusiform gyrus for the KGT group (p = 0.002). Furthermore, the absolute CBF difference before and after treatment in the fusiform gyrus was significantly lower in the KGT group than in the placebo group (p = 0.024).

CONCLUSIONS

Although a KGT treatment of 24 weeks showed some significant impact on the level of CBF, the Korean version of the mini-mental state examination score was not significantly different between before and after treatment conditions, indicating that there was no memory function improvement after treatment in amnestic MCI patients. Therefore, further studies should be performed with a relatively larger population and extending the duration of the KGT treatment.

摘要

目的

使用磁共振成像(MRI)评估葛根汤对轻度认知障碍(MCI)患者脑代谢物、神经递质和脑血流(CBF)的治疗效果。

方法

我们将 30 名 MCI 患者随机分为葛根汤(KGT)组(N=16)或安慰剂组(N=14),并在 24 周治疗前后进行 MRI 扫描。参与者接受脑磁共振波谱和 MRI 扫描,使用点分辨波谱(PRESS)单体波谱获得脑代谢物,使用 Mescher-Garwood PRESS 获得γ-氨基丁酸(GABA)神经递质,使用伪连续动脉自旋标记序列使用 3.0T MRI 系统获得 CBF。我们使用重复测量方差分析来分析代谢物和神经递质水平以及 CBF,以评估受试者间组效应、受试者内治疗条件效应以及组间条件的交互作用(组×条件)。

结果

治疗前后 GABA+/肌酸(Cr)比值无显著差异。治疗前后 KGT 组谷氨酸复合物/Cr 比值差低于安慰剂组,但无统计学意义(p=0.077)。基于感兴趣区的 CBF 测量结果显示,KGT 组(p=0.003)和安慰剂组(p=0.011)Cluster 2 治疗后 CBF 值明显降低,KGT 组(p=0.004)和安慰剂组(p=0.008)海马体,KGT 组(p=0.002)和安慰剂组(p=0.008)梭状回。此外,KGT 组治疗前后梭状回的绝对 CBF 差异明显低于安慰剂组(p=0.024)。

结论

虽然 KGT 治疗 24 周后对 CBF 水平有一定影响,但治疗前后韩国版简易精神状态检查评分无显著差异,表明遗忘型 MCI 患者治疗后记忆功能无改善。因此,应进行进一步的研究,纳入更多的患者,并延长 KGT 治疗的时间。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74e8/8598148/38a82338ca9c/ACM2-22-151-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验